Med Spa Patient Lifetime Value: How to Calculate Yours Properly

Vendor ROI calculators love a big lifetime value number, because it makes every argument easier. Aggregated industry data puts average med spa patient lifetime value somewhere around $1,800 to $5,200 over twelve months — a wide range, and one that says very little about your practice specifically.

Why the range is so wide

Because 'med spa' covers wildly different businesses. A practice built on neurotoxin maintenance has a different economic shape from one built on device-based body contouring or one running a weight-loss programme. Treatment mix, geography, positioning, membership structure and retention all move the number substantially.

Any vendor who applies a single industry figure to your ROI case is doing arithmetic, not analysis.

Calculating yours

Start narrow and honest. Take patients who first attended twelve to eighteen months ago, so you have a full cycle of data, and calculate the total revenue each has generated since. Average it. That is your twelve-month patient value — a defensible number you can plan against.

• First treatment value — what she spent on day one
• Repeat frequency — how many times she returned in twelve months
• Treatment expansion — whether she added services beyond the original one
• Retention — what share of first-time patients returned at all

The number that matters for follow-up decisions

For deciding whether to invest in consultation recovery, use first-year value rather than an optimistic lifetime projection. Recovering a patient who returns for a decade is wonderful, but you cannot bank a ten-year assumption when you are deciding this quarter's spend.

Retention is where the leverage sits

Most aesthetic treatments have a natural cycle. Neurotoxin wears off. Filler softens. Laser packages have a next session. A patient who does not rebook has not usually made a decision to leave — she has simply not been reminded at the moment the treatment stopped working.

AmSpa's reporting has shown repeat patient rates rising across the sector, from around 65% to 73% between 2022 and 2024. The practices moving that number are generally the ones with a recall process rather than better luck.

What to do with the number once you have it

Two things. First, set an acquisition ceiling: what you can afford to pay for a new patient given what she is worth in her first year. Second, price your follow-up and recall efforts against it — if recovering one patient a quarter covers the cost of the system doing the recovering, the decision is straightforward and does not require an inflated benchmark to justify.

A caution about vendor maths

If a proposal multiplies a large lifetime value by an optimistic recovery rate to produce a striking annual figure, ask for the same calculation using your own first-year value and a conservative recovery assumption. If it still works, it is a real case. If it only works with the generous inputs, you have learned something important.